Issue navigation
Volume 23, Issue 9, 1 September 2017
Letters to the Editor
Transmural Healing and MRI Remission: New Promising Therapeutic Targets in Crohn's Disease
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages E44–E45, https://doi.org/10.1097/MIB.0000000000001219
Standardizing Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Page E47, https://doi.org/10.1097/MIB.0000000000001229
Colon Capsule Endoscopy: Looking Beyond the Colon in Crohn's Disease
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages E43–E44, https://doi.org/10.1097/MIB.0000000000001224
Useful Trick for Discovering Granuloma in Gastric Crohn's Disease
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages E42–E43, https://doi.org/10.1097/MIB.0000000000001190
Importance of Considering the Financial Cost in Assessing Quality of Care
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages E47–E48, https://doi.org/10.1097/MIB.0000000000001226
IBD HINTS for Preventive Care
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Page E42, https://doi.org/10.1097/MIB.0000000000001177
Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages E46–E47, https://doi.org/10.1097/MIB.0000000000001225
Reply
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages E45–E46, https://doi.org/10.1097/MIB.0000000000001227
IBD Live
Health Care Services in IBD: Factors Associated with Service Utilization and Preferences for Service Options for Routine and Urgent Care
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1461–1469, https://doi.org/10.1097/MIB.0000000000001215
Commentary
Opening Doors for Urgent IBD Access: Harder than It Looks
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1470–1472, https://doi.org/10.1097/MIB.0000000000001207
IBD Live
Individualized Infliximab Treatment Guided by Patient-managed eHealth in Children and Adolescents with Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1473–1482, https://doi.org/10.1097/MIB.0000000000001170
Characterizing the Posttransfer Period Among Patients with Pediatric Onset IBD: The Impact of Academic Versus Community Adult Care on Emergent Health Resource Utilization
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1483–1491, https://doi.org/10.1097/MIB.0000000000001200
Management of the Psychological Impact of Inflammatory Bowel Disease: Perspective of Doctors and Patients—The ENMENTE Project
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1492–1498, https://doi.org/10.1097/MIB.0000000000001205
Clinical Review Article
Inflammatory Bowel Diseases: Review of Known Environmental Protective and Risk Factors Involved
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1499–1509, https://doi.org/10.1097/MIB.0000000000001217
Therapeutic Drug Monitoring During Induction of Anti–Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1510–1515, https://doi.org/10.1097/MIB.0000000000001231
Future Directions and Methods for IBD Research
Machine Learning–Based Gene Prioritization Identifies Novel Candidate Risk Genes for Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1516–1523, https://doi.org/10.1097/MIB.0000000000001222
Original Article
CD103+ Dendritic Cell Function Is Altered in the Colons of Patients with Ulcerative Colitis
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1524–1534, https://doi.org/10.1097/MIB.0000000000001204
E-cadherin Mediates the Preventive Effect of Vitamin D3 in Colitis-associated Carcinogenesis
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1535–1543, https://doi.org/10.1097/MIB.0000000000001209
Integrated Analysis of Biopsies from Inflammatory Bowel Disease Patients Identifies SAA1 as a Link Between Mucosal Microbes with TH17 and TH22 Cells
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1544–1554, https://doi.org/10.1097/MIB.0000000000001208
Thiopurines Dosed to a Therapeutic 6-Thioguanine Level in Combination with Adalimumab Are More Effective Than Subtherapeutic Thiopurine-based Combination Therapy or Adalimumab Monotherapy During Induction and Maintenance in Patients with Long-standing Crohn's Disease
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1555–1565, https://doi.org/10.1097/MIB.0000000000001183
Commentary
Combination Therapy with Dose Optimized Thiopurine and Adalimumab in Crohn's Disease
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1566–1567, https://doi.org/10.1097/MIB.0000000000001185
Original Article
Clinical Predictors of Future Nonadherence in Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1568–1576, https://doi.org/10.1097/MIB.0000000000001201
Longitudinal Patterns of Medication Nonadherence and Associated Health Care Costs
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1577–1583, https://doi.org/10.1097/MIB.0000000000001165
Long-term Outcomes with Anti-TNF Therapy and Accelerated Step-up in the Prospective Pediatric Belgian Crohn's Disease Registry (BELCRO)
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1584–1591, https://doi.org/10.1097/MIB.0000000000001193
Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1592–1599, https://doi.org/10.1097/MIB.0000000000001148
Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1600–1604, https://doi.org/10.1097/MIB.0000000000001157
Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus—A Multicenter Retrospective Study
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1605–1613, https://doi.org/10.1097/MIB.0000000000001160
Development and Validation of a Novel Prediction Model for Differential Diagnosis Between Crohn's Disease and Intestinal Tuberculosis
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1614–1623, https://doi.org/10.1097/MIB.0000000000001162
Autoantibodies Against Glycoprotein 2 Isoforms in Pediatric Patients with Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1624–1636, https://doi.org/10.1097/MIB.0000000000001159
Extraintestinal Manifestations Are Common in Obese Patients with Crohn's Disease
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1637–1642, https://doi.org/10.1097/MIB.0000000000001187
Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease: A Prospective Cohort Study
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1643–1649, https://doi.org/10.1097/MIB.0000000000001173
Vitamin D Status Is Associated with Hepcidin and Hemoglobin Concentrations in Children with Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1650–1658, https://doi.org/10.1097/MIB.0000000000001178
The Characteristics and Long-term Outcomes of Pediatric Crohn's Disease Patients with Perianal Disease
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1659–1665, https://doi.org/10.1097/MIB.0000000000001171
